Medically Reviewed
Reviewed by Dr. Elena Vasquez, PhD in Nutritional Science Β· PhD, MSc
Last reviewed: 25 April 2026
Medical disclaimer: The information in this article is for educational purposes only. Always consult a qualified healthcare professional before making significant dietary or lifestyle changes, especially if you have a medical condition.
Bone is not static scaffolding β it is a living tissue in continuous renewal. Approximately 10 % of your skeleton is replaced each year through a cycle of resorption (old bone broken down by osteoclasts) and formation (new bone laid down by osteoblasts). This dynamic system allows bone to adapt to mechanical demands, repair microdamage, and release mineral reserves during calcium shortfalls. For women, two biological turning points define bone health across the lifespan: peak bone mass, achieved between ages 25 and 30, and the menopausal oestrogen decline that accelerates resorption from the mid-40s onwards. Understanding both β and what you can do to maximise the first and mitigate the second β is the foundation of effective bone health strategy.
The Bone Remodelling Cycle and Peak Bone Mass
Bone remodelling occurs in discrete cycles at specific anatomical sites called basic multicellular units (BMUs). The cycle begins when osteoclasts are activated to resorb old or microdamaged bone over approximately 3 weeks, creating a microscopic cavity. Osteoblasts then fill this cavity with new collagen matrix (osteoid), which mineralises over the following 3β4 months. The net balance between resorption and formation determines whether bone density increases, remains stable, or decreases.
In childhood and adolescence, formation significantly exceeds resorption β bone density increases rapidly. This accumulation plateaus in the mid-20s and reaches its lifetime maximum β peak bone mass β typically between ages 25 and 30. The size of your peak bone mass is your primary buffer against osteoporosis later in life: a woman who achieves a higher peak bone mass can sustain substantially more bone loss before crossing the clinical threshold for osteoporosis.
Genetics determines approximately 60β80 % of peak bone mass. The remaining 20β40 % is modifiable β through calcium and vitamin D intake during childhood and adolescence, physical activity (particularly impact loading), and avoiding bone-depleting factors (smoking, excessive alcohol, glucocorticoid medications, low body weight).
After age 30, bone remodelling remains in approximate balance until the mid-40s to early 50s in women, when oestrogen levels begin declining. The decline in oestrogen dramatically shifts the remodelling balance towards resorption, accelerating bone loss at a rate of 1β3 % per year in the perimenopausal period.
Bone density is most responsive to interventions during periods of active remodelling: adolescence, the perimenopausal transition, and immediately after menopause. Waiting until a fracture occurs before addressing bone health misses the most impactful windows.
Calcium: How Much, Which Forms, and Absorption Cofactors
Calcium is the primary structural mineral of bone β approximately 99 % of the body's calcium is stored in the skeleton and teeth. Dietary calcium adequacy is fundamental to maintaining bone mineral density, yet surveys consistently show that a significant proportion of women β particularly those avoiding dairy β fall below recommended intakes.
Recommended calcium intakes by life stage: - Women aged 19β50: 1,000 mg per day - Women aged 50+: 1,200 mg per day - Adolescent girls aged 9β18: 1,300 mg per day (the highest requirement of any life stage)
Food sources and their calcium content per typical serving: - Full-fat milk (240 ml): approximately 300 mg - Plain yogurt (200 g): 250β350 mg - Hard cheese such as Cheddar or Parmesan (30 g): 200β330 mg - Canned sardines with bones (100 g): approximately 350 mg - Firm tofu made with calcium sulphate (100 g): 200β350 mg - Cooked kale or bok choy (150 g): approximately 150 mg - Fortified plant milks (240 ml): typically 300 mg if fortified - Almonds (30 g): approximately 75 mg
Calcium absorption is not a simple function of intake β it is profoundly affected by cofactors. Vitamin D3 is the most critical: it upregulates calcium-binding proteins in the intestinal wall and dramatically increases fractional calcium absorption. Without adequate vitamin D (serum 25-OH-D above 50 nmol/L), calcium absorption efficiency falls from approximately 30β40 % to 10β15 %. Vitamin K2 directs calcium into bone and away from arteries. Magnesium is required for the hydroxylation of vitamin D into its active form and for osteoblast function.
βCalcium supplementation must be considered in the context of vitamin D status β without adequate vitamin D, dietary calcium cannot be effectively absorbed regardless of intake level.β
β Weaver et al., Osteoporosis International, 2016
Vitamin D3 and K2: The Essential Cofactors
Vitamin D3 (cholecalciferol) is synthesised in the skin through UV-B exposure β approximately 10β15 minutes of midday sun exposure to arms and face in summer at temperate latitudes produces 2,000β4,000 IU. During autumn and winter at latitudes above 40Β° north (which includes all of the UK, much of northern Europe, and the northern United States), UV-B intensity is insufficient for adequate synthesis for 4β6 months of the year. Dietary vitamin D is found naturally in very few foods: oily fish (salmon, mackerel, herring) provide 400β1,000 IU per serving; egg yolks and liver contribute modest amounts.
Public Health England recommends 400 IU (10 mcg) of vitamin D supplementation daily for all UK adults during autumn and winter; many bone health researchers argue 1,000β2,000 IU per day is more appropriate for people at elevated fracture risk, particularly postmenopausal women. Target serum 25-OH-D level for bone health is typically cited as above 75 nmol/L in specialist osteoporosis guidance.
Vitamin K2 (menaquinone) is distinct from vitamin K1 (phylloquinone, found in green vegetables). K2 activates osteocalcin β a protein that binds calcium and anchors it within the bone matrix β and activates matrix Gla protein, which prevents calcium from depositing in arterial walls. K2 is found primarily in fermented foods (natto, aged hard cheeses, fermented dairy) and in animal products from grass-fed animals. Supplemental K2 as MK-7 (menaquinone-7) at 100β200 mcg per day is the most bioavailable and longest-acting form.
Exercise and Bone Density: Impact Loading vs Non-Impact Activity
Exercise stimulates bone formation through a mechanism called mechanotransduction: mechanical stress on bone causes fluid movement through tiny channels in bone tissue (canaliculi), which osteocytes (bone-sensing cells) detect and translate into signals for osteoblast activation and new bone formation. The key word is mechanical stress β and not all exercise provides it.
Impact loading exercises β those that produce ground reaction forces above body weight β are the most effective for stimulating bone formation. These include jumping and plyometrics (vertical jump, jump rope, box jumps β producing ground reaction forces of 3β5 times body weight), running (2.5β3 times body weight per stride), weightlifting and resistance training, and racquet sports with lateral and vertical impact forces.
Non-impact activities that are excellent for cardiovascular and muscular health but do not significantly stimulate bone formation: swimming (water buoyancy eliminates impact loading; studies consistently show swimmers have similar or lower bone density than age-matched sedentary controls) and cycling (associated with reduced lumbar spine bone density in studies of committed cyclists).
This does not mean swimming and cycling are harmful to bone β they maintain other dimensions of health important for overall fracture risk. But women who swim or cycle exclusively should add some form of impact loading to their exercise routine.
Resistance training deserves special emphasis. Progressive resistance training β using weights heavy enough to challenge the musculoskeletal system β is one of the few interventions shown to increase bone mineral density in postmenopausal women in randomised controlled trials. Effective programmes include squats, deadlifts, overhead press, and rows β all exercises that load the spine, hips, and wrists, the three sites most vulnerable to osteoporotic fracture.
For bone density, jumping is highly effective and underused. A programme of 10β20 high-impact jumps per day β even simple two-footed vertical jumps β has been shown in trials to produce measurable bone density improvements in postmenopausal women over 12 months.
Oestrogen's Role and Post-Menopausal Bone Loss
Oestrogen is the primary regulator of bone remodelling balance in women. It acts on both osteoclasts (suppressing their activity and lifespan) and osteoblasts (promoting their function and survival). When oestrogen declines during perimenopause and menopause, osteoclast activity increases while osteoblast survival decreases β the remodelling balance tips sharply towards resorption.
In the first 5 years after menopause, women can lose 2β3 % of bone density per year β a rate that may be 5β10 % in early surgical menopause (ovary removal). Over a decade, this represents a bone mass loss that substantially elevates fracture risk: by age 75, a woman with an average post-menopausal trajectory has approximately twice the fracture risk of a man of the same age.
Hormone replacement therapy (HRT/MHT) is the most effective pharmacological intervention for post-menopausal bone loss: it substantially preserves bone density and reduces fracture risk. The risk-benefit analysis of HRT for bone health is complex and highly individualised β women should discuss this with their GP or gynaecologist in the context of their specific health history.
Non-HRT pharmacological options include bisphosphonates (alendronate, risedronate), RANK-L inhibitors (denosumab), and SERMs (raloxifene) β all of which have evidence for fracture risk reduction.
For lifestyle interventions post-menopause: calcium and vitamin D adequacy becomes even more critical as intestinal calcium absorption efficiency declines; weight-bearing and resistance exercise should be maintained or increased; fall prevention becomes increasingly important (balance training, vision correction, home hazard assessment); and smoking cessation is essential β smokers have significantly lower oestrogen levels and faster bone loss.
Key Takeaways
Building and protecting bone density is a lifelong project with two critical windows: the bone-building phase before age 30, and the protective phase post-menopause. Calcium adequacy, vitamin D3 and K2 status, regular impact loading and resistance training, and oestrogen management are the evidence-supported pillars of bone health for women. The earlier these strategies are implemented, the more bone you start with β but it is never too late to slow loss, support bone quality, and reduce fracture risk.
Frequently Asked Questions
How much calcium is too much?βΌ
Is dairy the best source of calcium for bone health?βΌ
Can you rebuild bone density once it is lost?βΌ
Should I take calcium supplements if I don't eat dairy?βΌ
Does coffee or alcohol harm bone density?βΌ
References
- [1]Weaver CM et al. (2016). βCalcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.β Osteoporosis International. PMID: 26510847
- [2]Booth SL et al. (2000). βVitamin K intake and bone mineral density in women and men.β American Journal of Clinical Nutrition. PMID: 10683008
- [3]Warden SJ et al. (2014). βBone response to exercise with and without impact.β Bone. PMID: 24472633
- [4]Riggs BL et al. (1998). βA unitary model for involutional osteoporosis: oestrogen deficiency causes both type I and type II osteoporosis in postmenopausal women.β Journal of Bone and Mineral Research. PMID: 9718198
More in Women's Health
View all βAbout This Article
Written by Dr. Elena Vasquez, PhD in Nutritional Science. Published 10 October 2025. Last reviewed 25 April 2026.
This article cites 4 peer-reviewed sources. See the full reference list below.
Editorial policy: All content is reviewed for accuracy and updated when new evidence emerges. Health articles include a medical disclaimer and are reviewed by qualified professionals.
About the Author
Research scientist specialising in metabolic health, fasting biology and the gut microbiome.